PP
TTOO

Paloma Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Paloma Partners’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28
Closed -$235K – 2363
2019
Q2 		$235K Buy
+28
New +$328K ﹤0.01% 1442
2017
Q3 		– Sell
-11
Closed -$177K – 2522
2017
Q2 		$177K Buy
+11
New +$220K ﹤0.01% 2022

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Paloma Partners's TTOO Position: Q3 2019 in Review

Paloma Partners sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 28 shares — an estimated $235K sold.

Paloma Partners first reported a position in TTOO in Q2 2017 and held it in 2 quarters. The position peaked at $235K in Q2 2019. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

  • Paloma Partners reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
  • Paloma Partners sold 28 T2 Biosystems, Inc shares in Q3 2019, an estimated $235K.
  • Paloma Partners first reported a position in T2 Biosystems, Inc in Q2 2017 and held it in 2 quarters.
  • Paloma Partners's T2 Biosystems, Inc position peaked at $235K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.